Study Spotlight

Study Spotlight

Fish Oil Supplementation May Improve Lipid Profile and Reduce Inflammation in the Metabolic Syndrome


In a study involving 140 patients with the metabolic syndrome and/or non-alcoholic fatty liver disease (NAFLD), daily supplementation with fish oil (2 g/d) for a period of 6 months was found to be associated with reductions in serum triglycerides, LDL-cholesterol, H(2)O(2), MDA, TNF-alpha, and IL-6 levels. Patients who did not receive fish oil were found to have significant increases in triglycerides, LDL, H(2)O(2) and MDA, which were associated with elevated TNF-alpha and IL-6. The authors state, "...daily treatment of patients with fish oil for 6 months improved lipid profile and blocked the oxidative stress and cytokines release."

Click Here to visit the journal website. Subscription required to view the full text of the article.

Socialize
Website by Webfitters